13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
ISSUER PROFILE · CIK 0001672619

Enliven Therapeutics, Inc.ELVN

5 13D/G filings 3 distinct filers 0 insider transactions (365d)

Cross-Reference Snapshot

Activist filings
5
5 SC
Distinct filers
3
multi-activist cluster
Insiders (365d)
0
0 buys · 0 sales
Latest short DTC
2.86
as of 2026-03-31

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $23.17M
Point72 Asset Mgmt

13D/G Filings Timeline · 5 total

FiledFormFilerStakeSharesIntent
2023-08-28 SC 5AM Ventures VI, L.P. view →
2022-05-24 SC New Enterprise Associates 14, L.P. view →
2022-01-10 SC New Enterprise Associates 14, L.P. view →
2021-07-20 SC Arix Bioscience plc view →
2021-01-08 SC Arix Bioscience plc view →

FINRA Short Interest History

SettlementShort InterestDays to Cover% Δ vs prior
2026-03-31 6,053,456 2.86 -26.3%
2026-03-13 8,215,500 10.54 +3.0%
2026-02-27 7,979,674 12.26 -1.2%
2026-02-13 8,078,549 11.21 +2.6%
2026-01-30 7,870,182 7.89 -14.1%
2026-01-15 9,166,736 4.19 +10.3%
2025-12-31 8,312,949 11.85 +2.5%
2025-12-15 8,111,262 9.81 +1.4%

Alert me when any activist files on Enliven Therapeutics, Inc.

Free. We email you when criteria match. One-click unsubscribe in every email.

Track every activist who touches this name.

Custom alerts · full feed · daily intelligence · API. $1,500/mo. Pilots welcome.

Request a pilot →